GW Pharmaceuticals

(NASDAQ: GWPH)
Healthcare  |  Drug Manufacturers—General
113.95 4.58 4.19%
Stock Price | Aug. 10, 2020, 4 p.m.
15 Followers
Bid: 111.39
Ask: 113.95
Prev. Close: 109.37
52 Week Low: 67.98
52 Week High: 175.35
PE Ratio: 91.141667
Dividend Yield: 0.0%

Company Summary

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - AM Edition 8/10/20

16 Comments
7 hours ago

Premium Weekly Review 08/07/20

3 days ago

Premium Cannabis Stocks Review - AM Edition 08/07/20

34 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/07/20

3 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/05/20

1 Comments
5 days ago

Premium Cannabis Stocks Review - AM Edition 08/03/20

21 Comments
1 week ago

Premium Earnings Previews for the Week Ending 08/7/20

1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 07/24/20

3 Comments
2 weeks ago

Premium Cannabis Stocks Review - AM Edition 07/20/20

9 Comments
3 weeks ago

Premium Cannabis Stocks Review - AM Edition 07/15/20

8 Comments
3 weeks ago